- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02818166
Magnetic Resonance Imaging for Cerebral Embolization During Minimal Invasive Mitral Valve Surgery
Magnetic Resonance Neurological Evaluation After Right Mini-thoracotomy Mitral Valve Surgery: Trans-thoracic Versus Endoaortic Clamp
The purpose of this study is to prospectively evaluate major and minor neurologic events in patients undergoing right mini-thoracotomy mitral valve surgery and to compare different aortic clamping techniques; specifically, the endoaortic balloon with retrograde perfusion (Endoreturn) and the transthoracic clamp with retrograde perfusion. Major neurologic events will be evaluate through standard neurologic evaluation; minor neurologic events will be evaluate through magnetic resonance (MR) assessment.
The first aim of the study is to determine the number and impact of microembolic events during right mini-thoracotomy mitral valve surgery on clinical neurological status and on MR evaluation. The investigators also aim to determine if different techniques of aortic clamping may impact on early outcome.
Study hypothesis: despite recent concerns arising about endoaortic balloon with retrograde perfusion, the investigators expect to show equivalence in term of safety and effectiveness of this technique compared with the transthoracic clamp in a selected population.
Study Overview
Status
Intervention / Treatment
Detailed Description
The incidence of neurologic events in right mini-thoracotomy mitral valve surgery compared with that of conventional surgery is a controversial issue and has been extensively studied. In the meta-analysis published by Modi et al, equal occurrence of neurologic events between patients who underwent MIMVS and those who underwent a median sternotomy was found. Conversely, the Thoracic Surgeons Adult Cardiac database and the Cleveland Clinic group concluded that the risk of stroke is significantly higher in the less invasive group.
Moreover, recent data have suggested that retrograde arterial perfusion, particularly in patients with severe arch/ascending aortic atherosclerosis, could be the source of the significant increase in the incidence of cerebral complications. The meta-analysis of Cheng, documents a 1.79 fold increase in the risk of stroke in the right thoracotomy group, but on subgroup analysis this appeared driven by a higher stroke risk in those studies reporting endoaortic balloon occlusion and not transthoracic clamping. Murzi et al. report a 4.28 fold increase in stroke risk with RAP in 1280 primary MIMVS patients. Grossi and colleagues show that the only significant risk factor for neurologic event was the use of retrograde perfusion in high-risk patients with aortic disease.
The purpose of this randomized blinded study is to prospectively evaluate major and minor neurologic events in patients undergoing right thoracotomy mitral valve surgery with retrograde perfusion and endoaortic balloon clamp (Endoreturn) or transthoracic clamp. Major neurologic events will be evaluate through standard neurologic evaluation; minor neurologic events will be evaluate through magnetic resonance assessment.
MR evaluation will be performed by blinded radiologists. MR will be performed with a 3T system (Philips INGENIA 3T). The protocol includes conventional sequences for the morphological and quantitative assessment (3D-FLAIR, 3D-T1-TSE, DWI, T2-FFE) and non conventional sequences for the white matter microstructural evaluation (Diffusion Tensor Imaging - DTI with fractional anisotropy and mean diffusivity). No contrast enhanced will be used.
Patients who have no contraindications will undergo cerebral MR before surgery as baseline assessment. Then, they will be randomized in one of the 2 groups.
If no contraindications arise in the postoperative period (eg definitive pacemaker implantation), patients will undergo cerebral MR before the discharge, to highlight the presence of new ischemic lesions, even clinically silent.
After 6 months, patients who developed new ischemic lesions revealed by the post-operative cerebral MR will repeat a new MR to assess evolution of cerebral damage Neurologic assessment will be performed by blinded specialists of the Neurology Department.
Type of the study:
Single center randomized blinded study that will be performed at the University of Turin, Città della Salute e della Scienza Hospital and will include:
Cardiac Surgery department. Neuroradiology department.
Aims of the study:
To determine the incidence of new lesions on pre-discharge MR in patients undergoing right mini-thoracotomy mitral valve surgery according to different aortic clamping techniques.
To assess the correlation between clinical neurological peri-procedural events (TIA, Stroke), and the occurrence of new lesions on pre-discharge MR.
To assess the evolution of new cerebral ischemic lesions between pre-discharge MR and follow-up MR (more than 6 months later).
To the investigators knowledge this is the first randomized blinded study that will compare two right mini-thoracotomy techniques for mitral valve surgery on a selected population (without risk factors for neurological events) with MR.
The result of this study will be able to allow surgeons to choose the best and less dangerous method in case of mini-invasive operations. This could rapresent a fundamental step in confirming the efficacy and safety of mini-invasive approaches for mitral valve surgery and resulting, in addition, in the reduction of the costs of these procedures.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Turin, Italy, 10126
- Recruiting
- University of Turin - Cardiothoracic Department
-
Contact:
- Mauro Rinaldi, MD
- Phone Number: +390116335511
- Email: mauro.rinaldi@unito.it
-
Principal Investigator:
- Cristina Barbero, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age between 18 and 80 years.
- Indication for elective mitral valve surgery +/- tricuspid valve surgery through right mini-thoracotomy.
- No contraindication for MR
Exclusion Criteria:
- Neuro-cognitive diseases;
- Peripheral vascular disease;
- Atrial fibrillation;
- PFO o interatrial defect;
- Previous Stroke;
- Autoimmune diseases;
- Neoplastic diseases;
- Migraine;
- Celiac disease;
- Alchool or drug abuse;
- Contraindication for MR.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Endoaortic Clamp
Right mini-thoracotomy mitral valve surgery with retrograde perfusion and endoaortic balloon clamp
|
Right mini-thoracotomy mitral valve replacement/repair.
|
|
Active Comparator: Transthoracic Clamp
Right mini-thoracotomy mitral valve surgery with retrograde perfusion and transthoracic clamp.
|
Right mini-thoracotomy mitral valve replacement/repair.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
MR microembolization
Time Frame: untill 3 days after surgical procedure
|
To determine the incidence of new lesions on pre-discharge MR in patients undergoing right mini-thoracotomy mitral valve surgery according to different aortic clamping techniques.
|
untill 3 days after surgical procedure
|
|
Clinical events and MR outcome correlation
Time Frame: untill 3 days after surgical procedure
|
To assess the correlation between clinical neurological peri-procedural events (TIA, Stroke), cognitive / neuropsychological status and the occurrence of new lesions on pre-discharge MR.
|
untill 3 days after surgical procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evolution of MR lesions
Time Frame: 3 month follow up
|
To assess the evolution of new cerebral ischemic lesions between pre-discharge MR and follow-up MR (3 months later)
|
3 month follow up
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Turin University
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mitral Valve Insufficiency
-
Abbott Medical DevicesCompletedMitral Valve Regurgitation | Mitral Valve Incompetence | Mitral Insufficiency | Functional Mitral Regurgitation | Mitral Stenosis With InsufficiencyJapan
-
Universitätsklinikum Hamburg-EppendorfUniversity Hospital, Bordeaux; Montreal Heart InstituteRecruitingMitral Regurgitation | Mitral Valve Disease | Mitral Annular CalcificationSwitzerland, United States, Denmark, United Kingdom, France, Austria, Canada, Italy, Germany, Greece, Poland, Australia, Norway
-
4C Medical Technologies, Inc.RecruitingMitral Regurgitation | Mitral Valve Regurgitation | Mitral Valve Incompetence | Mitral Insufficiency | Mitral IncompetenceUnited States, Spain, Germany, Greece
-
Abbott Medical DevicesCompletedMitral Regurgitation | Mitral Valve Insufficiency | Mitral Valve Regurgitation | Mitral Valve Incompetence | Mitral InsufficiencyUnited States
-
Abbott Medical DevicesCompletedMitral Regurgitation | Mitral Valve Insufficiency | Mitral Valve Regurgitation | Mitral Valve Incompetence | Mitral InsufficiencyUnited States
-
Abbott Medical DevicesRecruiting
-
Abbott Medical DevicesActive, not recruitingCardiovascular Diseases | Heart Valve Diseases | Mitral Regurgitation | Mitral Valve Insufficiency | Valve Disease, Heart | Mitral Insufficiency | Functional Mitral Regurgitation | Degenerative Mitral Valve DiseaseCanada, United States
-
Abbott Medical DevicesCompletedMitral Regurgitation | Mitral Valve Insufficiency | Mitral Valve Regurgitation | Mitral Valve Incompetence | Mitral InsufficiencyUnited States
-
Abbott Medical DevicesCompletedMitral Regurgitation | Mitral Valve Insufficiency | Mitral Valve Regurgitation | Mitral Valve Incompetence | Mitral InsufficiencyUnited States
-
4C Medical Technologies, Inc.RecruitingMitral Regurgitation | Mitral Valve Regurgitation | Mitral Valve Incompetence | Mitral Insufficiency | Mitral IncompetenceUnited States
Clinical Trials on Mitral valve surgery
-
Guy's and St Thomas' NHS Foundation TrustKing's College Hospital NHS Trust; Royal Brompton & Harefield NHS Foundation... and other collaboratorsNot yet recruitingMitral Regurgitation
-
Michele De BonisCompletedMitral Regurgitation | Aortic RegurgitationItaly
-
Meshalkin Research Institute of Pathology of CirculationCompletedHypertrophic Obstructive CardiomyopathyRussian Federation
-
University Hospital, Basel, SwitzerlandCompletedMitral Valve Disease | Mitral Valve SurgerySwitzerland
-
Karolinska InstitutetKarolinska University HospitalRecruitingMitral Regurgitation | Ventricular Tachycardia | Mitral Valve ProlapseSweden
-
University Hospital, Basel, SwitzerlandWithdrawn
-
Atlantic Health SystemUnknownMitral Valve InsufficiencyUnited States
-
Ettore Sansavini Health Science FoundationUnknownTricuspid (Valve) Insufficiency (Rheumatic)Italy
-
Instituto Dante Pazzanese de CardiologiaEdwards LifesciencesCompletedMitral Prosthetic Valve Stenosis and RegurgitationBrazil
-
University of Maryland, BaltimoreEdwards LifesciencesCompletedCardiac Surgery | Tricuspid Valve RegurgitationUnited States